Delivery Order SPE2DB20D3101-SPE2DB23FRHJ1
Award Date 4/7/23
Potential Completion Date 4/10/23
Potential Value $14K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of 4563816196 Ondansetron ODT 4 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA). The $16,342.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The ultimate completion date for this order is March 1, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $14,868.82 and an ultimate completion date of October 25, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract was awarded through full and open competition...
- This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,803.16 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a completion date of November 8, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,685.40, is a firm-fixed-price delivery order with a completion date of February 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
- This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,012.06 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical...
- This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $17,460.11 and is a firm fixed-price delivery order, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite...
- This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The $21,785.15 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $3,263.59, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of December 14, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron HCL 4 mg tablets. The contract, valued at $2,938.89, is a Firm Fixed Price Delivery Order with a completion date of December 5, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of Ondansetron HCl 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,068.40 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a period of performance through March 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive...